Transparency Market Research estimates that the global urolithiasis management devices market will expand at a healthy 4.5% CAGR over the period between 2016 and 2024. The market’s worth is estimated to be US$1.26 bn in 2016 and is expected to rise to US$1.78 bn by 2024.
Urolithiasis is development of kidney stones in the urinary system. It includes nephrolithiasis (development of kidney stones), ureterolithiasis (stone formation in ureters), and cystolithiasis (stone formation in the bladder). Urolithiasis is a common condition that affects at least 10% of the global population. Urinary stones are generally distinguished based on the location and chemical composition. Based on chemical composition, these are categorized into calcium, uric acid, and oxalate stones.
Kidney stones can be managed through different methods. The natural method involves improving quality of life. Other methods include drug treatment and kidney stone management devices. Major factors driving the kidney stone management devices market are rising geriatric population, increasing awareness, advancements in technology of the devices due to various external factors such as entry of new market players, increasing investment, and government initiatives.
This report on the global urolithiasis management devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. A detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market related factors such as increasing preference for efficacious products, product innovation, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global urolithiasis management devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, clinical trials, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
The global urolithiasis management devices market has been segmented based on device type, end-user, and geography. Urolithiasis management devices are categorized into shockwave lithotripters and ureterorenoscopes. Shockwave Lithotripters include ultrasound lithotripters, pneumatic lithotripters, and laser lithotripters. Ureterorenoscopes include rigid, semi-rigid, and flexible ureterorenoscopes. Shock wave lithotripters accounts for the major share of the urolithiasis management devices market. Extracorporeal lithotripters dominate the market; however, the laser lithotripters and flexible ureterorenoscopes segments are expected to witness high compound annual growth rate during the forecast period.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2252
The major distribution channels for usage of urolithiasis management devices products include hospitals, clinics, and ambulatory surgical centers. Ambulatory surgical centers are set to witness rapid growth due to the various benefits ranging from affordability to the ease of access and available advanced technologies. These benefits include easy shipping, huge discounts, and convenience of purchasing from any location.
Geographically, the market has been segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. North America accounted for the largest share of the global urolithiasis management devices market. The market in Asia Pacific is anticipated to expand at the fastest growth rate from 2016 to 2024.
Key players in the urolithiasis management devices market are Allengers Medical Systems Ltd, C. R. Bard, Inc., Cook Group, Inc., Dornier Medtech GmbH, DirexGroup, Karl Storz, Boston Scientific Corporation, Olympus Corporation, Siemens Healthcare, and Electro Medical Systems S.A.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453